Veradigm shares are trading higher after the company provided an update for its audit procedures and its FY23 guidance.
Portfolio Pulse from Benzinga Newsdesk
Veradigm, a subsidiary of Allscripts Healthcare Solutions (MDRX), has provided an update for its audit procedures and its FY23 guidance. This has led to a rise in the company's shares.
September 18, 2023 | 5:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Allscripts Healthcare Solutions' subsidiary Veradigm's update on its audit procedures and FY23 guidance has led to a rise in its shares, which could positively impact MDRX's stock.
Veradigm, being a subsidiary of Allscripts Healthcare Solutions (MDRX), its performance directly impacts the parent company. The positive update on audit procedures and FY23 guidance has led to a rise in Veradigm's shares, which is likely to have a positive impact on MDRX's stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100